Testosterone therapy for sexual dysfunction in men with Type 2 diabetes: a systematic review and meta ‐analysis of randomized controlled trials
ConclusionTestosterone therapy may moderately improve sexual desire and erectile function in men with Type 2 diabetes; however, available data are limited, and the long‐term risks of testosterone therapy are not known in this specific patient group. We conclude that testosterone therapy is a potential treatment for men with Type 2 diabetes non‐responsive to phosphodiesterase‐5 inhibitors. Testosterone therapy could be considered for men with Type 2 diabetes when potential risks and benefits of therapy are carefully considered and other therapeutic options are unsuitable.This article is protected by copyright. All rights reserved.
Source: Diabetic Medicine - Category: Endocrinology Authors: M. Algeffari, C. N. Jayasena, P. MacKeith, A. Thapar, W. S. Dhillo, N. Oliver Tags: Systematic Review or Meta ‐analysis Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Databases & Libraries | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Prostate Cancer | Reproduction Medicine | Sexual Dysfunction | Statistics | Study